The bean has become glucose, amino acids, minerals, microbial metabolites, and transformed plant compounds moving through different parts of the body.
But the existence of a molecule is not yet a cellular response.
A cell must encounter it.
The cell must contain a transporter, receptor, enzyme, ion channel, or other molecular system capable of responding to that chemical form at the concentration and location in which it appears.
Only then can the molecule change what the cell is doing.
This is the governing principle of the chapter:
The bean begins to influence cell behavior when its transformed products enter systems that cells can detect and respond to.
The Bean’s Journey Continues: the recipients appear
The bean has created several streams, and each stream meets different recipients.
Glucose and amino acids released in the small intestine encounter absorptive and endocrine cells before entering portal blood. Butyrate produced in the colon first encounters microorganisms, mucus, colonocytes, and nearby immune and endocrine cells. Acetate and propionate can enter portal circulation and reach the liver. Transformed polyphenol-related compounds appear in different chemical forms and at different times.
There is no single receptor for bean.
Instead, cells detect individual products of the journey.
The resulting exposures are distributed across organs and time.
Cells sense molecules in several ways
A cell can respond to a molecule through more than one mechanism.
A transporter moves a molecule across a membrane. Transport may allow the molecule to become fuel, building material, or an intracellular signal.
A receptor recognizes a molecule or a change outside or inside the cell and initiates a signaling pathway. The receptor does not need to consume the molecule in order to respond.
An enzyme transforms a molecule. The reaction may supply energy or building material, alter the concentration of a regulatory compound, or change the activity of the enzyme itself.
An ion channel changes the movement of charged particles across a membrane. This can alter electrical activity, secretion, contraction, or communication.
These categories overlap.
Transport changes intracellular concentration. Metabolism changes energy and chemical balance. Receptors alter signaling. Signaling changes enzymes, transporters, channels, and gene activity.
The cell integrates these inputs rather than reading each one in isolation.
The small intestine senses the bean first
The first major cellular response began before the microbiome entered the story.
As bean starch became glucose, glucose transport across the small-intestinal surface changed the chemical environment inside absorptive cells. Amino acids and small peptides entered through their own transport systems. Minerals crossed through regulated routes.
Enteroendocrine cells positioned among the intestinal epithelium sampled features of the meal and released hormones in response to nutrients and digestive conditions.
These cells are sparse, but their signals travel.
Hormones such as glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 participate in communication with the pancreas and other tissues. Cholecystokinin and peptide YY contribute to digestive regulation and satiation. Neural pathways carry additional information from the gut.
The bean therefore creates signals while it is being absorbed.
Its glucose is not merely fuel entering blood. Its arrival is detected within a coordinated digestive and endocrine system.
Yet the response belongs to the whole meal. Other carbohydrates, protein, fat, particle structure, gastric emptying, and the person’s metabolic state all influence the same signals.
The body senses the bean in context.
The colonocyte meets microbial butyrate
Butyrate provides the clearest example of a microbial product encountering a cellular recipient.
It is produced in the colonic lumen and arrives first at the apical surface of the colonocyte—the side facing the intestinal contents.
At colonic pH, much of the butyrate is present as a charged ion. Transport proteins help move it across the cell membrane. Monocarboxylate transporter 1, known as MCT1 and encoded by SLC16A1, is one route demonstrated in human colonic epithelial tissue and cell models.[1]
Transport establishes an intracellular exposure.
Once inside, butyrate can be activated and oxidized in mitochondria. The colonocyte converts its carbon into acetyl-CoA and uses it in energy metabolism.
In this situation, the microbial metabolite is not limited to surface-receptor signaling.
It becomes a substrate within the cell.
Its metabolism can alter ATP production, oxygen consumption, redox state, and the concentrations of metabolic intermediates. Those changes can influence other cellular processes.
Butyrate can also act without being burned
Not every butyrate molecule entering a cell is immediately oxidized.
Intracellular butyrate can interact with enzymes, including histone deacetylases. Inhibiting these enzymes can change the acetylation state of proteins and the regulation of gene expression.
That mechanism will be examined in the next chapter. Here, the important point is that one molecule can enter more than one sensing route.
Butyrate may:
- cross the membrane through a transporter;
- become an energy substrate;
- bind a cell-surface receptor;
- influence intracellular enzymes; or
- leave the cell and continue toward portal blood.
Which route matters most depends on concentration, cell type, metabolic state, and location.
A healthy mature colonocyte that efficiently oxidizes butyrate presents a different intracellular environment from an inflamed, immature, or transformed cell with altered metabolism.
The molecule is the same.
The recipient changes the response.
Enteroendocrine cells translate local chemistry into distant signals
The colon contains enteroendocrine cells capable of detecting luminal and absorbed molecules and releasing hormones.
Short-chain fatty acids can influence peptide YY production and secretion in human enteroendocrine cell and primary intestinal culture models. In those experiments, propionate and butyrate strongly increased PYY expression, with much of the response attributed to intracellular enzyme inhibition and a smaller contribution from FFAR2 signaling.[2]
Human intervention studies show that location matters.
In a 2026 randomized crossover trial, 28 healthy adults received the same mixture of short-chain fatty acids delivered either to the small intestine, to the colon, or as placebo. Colonic delivery produced a greater peptide YY response than small-intestinal delivery, while small-intestinal delivery produced higher circulating short-chain-fatty-acid concentrations and a different glucagon-like peptide-1 response.[3]
This experiment did not feed participants beans, and it delivered a defined metabolite dose rather than relying on microbial fermentation.
Its value for the Bean’s Journey is specific:
It demonstrates that the biological response to a microbial metabolite depends on where the exposure occurs—not merely on how much of the molecule exists.
If bean fermentation produces butyrate in the colon, the local endocrine opportunity differs from placing the same molecule elsewhere.
Hormones extend the response beyond the intestine
Hormones released by intestinal cells enter circulation or act through nearby nerves and tissues.
They can influence pancreatic secretion, gastrointestinal motility, appetite, and communication with the brain. These responses help coordinate the body’s handling of a meal.
This physiological observation has yet to be shown to be clinically relevant.
Portal blood carries metabolites to the liver
Metabolites absorbed from the colon enter portal circulation and reach the liver before most of the wider body.
The liver therefore encounters concentrated products from the digestive tract.
These products may include acetate, propionate, small amounts of butyrate, amino acids, glucose, minerals, bile acids, and transformed polyphenol-related compounds. The proportions change over time and with the meal, microbiome, absorption, and intestinal use.
Liver cells contain transporters, receptors, and enzymes capable of responding to these molecules. They can extract and metabolize short-chain fatty acids, modify phenolic metabolites, regulate glucose storage and release, process amino-acid nitrogen, and alter bile-acid synthesis.
The liver receives a changing chemical mixture rather than one uniform exposure.
The liver’s response depends on its existing state: energy demand, glycogen stores, insulin and glucagon signals, inflammation, circadian timing, and the other nutrients arriving with the meal.
The bean contributes to the input.
The liver integrates it with the rest of physiology.
Immune cells encounter the journey locally
Immune cells lie close to the intestinal epithelium and can encounter metabolites that cross the barrier or are transported within local tissue.
Short-chain fatty acids can act through receptors, transport, metabolism, and intracellular enzyme regulation in several immune-cell types. The response varies with cell identity and activation state.
Recent research using inflamed intestinal biopsies from people with inflammatory bowel disease, human colonic organoids, monocytes, and macrophages illustrates this cell specificity. Butyrate altered epithelial transport-related expression and suppressed several inflammatory features in monocytes and macrophages, with the investigators identifying inhibition of histone deacetylase 3 as a major mechanism in those immune cells.[4]
This is strong mechanistic evidence in disease tissue and experimental models.
It does not establish that a serving of beans treats inflammatory bowel disease. The study applied defined butyrate exposures directly to cells and tissues; it did not measure the complete path from bean consumption to clinical outcome.
The finding teaches a more general lesson:
Different cells can respond to the same metabolite through different dominant mechanisms.
Polyphenol-related metabolites meet different recipients
The bean’s phenolic compounds underwent digestion, microbial transformation, intestinal conjugation, and liver modification.
Cells may therefore encounter glucuronidated, sulfated, methylated, reduced, or cleaved metabolites rather than the native compound extracted from the bean.
These chemical changes affect transport, protein binding, distribution, clearance, and the molecular targets available to the compound.
A laboratory experiment that exposes cells to a high concentration of a native bean polyphenol may identify a possible mechanism. But if human plasma contains mainly a conjugated metabolite at a far lower concentration, the experiment does not reproduce the relevant exposure.
The correct question is not only Can this compound affect a cell?
It is:
Which bean-related form reaches this cell, at what concentration, and for how long?
Cellular sensing depends on the molecule that arrives, not the molecule that was easiest to purchase for an experiment.
Concentration determines which pathways are possible
A molecule may use one pathway at a low concentration and another at a high concentration.
Receptors have characteristic ranges of sensitivity. Transport can saturate. Enzymes respond according to substrate and inhibitor concentrations. High experimental exposures can create cellular stress unrelated to ordinary nutrition.
Butyrate illustrates the spatial problem.
Its concentration can be relatively high in the colonic lumen, lower within tissue and portal blood, and much lower in systemic circulation because colonocytes and the liver extract much of it.[5]
Therefore:
- a luminal mechanism may be realistic for colonocytes;
- a portal mechanism may be realistic for the liver;
- the same mechanism may be implausible in a distant tissue if circulating exposure is too low.
This does not mean distant effects are impossible. Hormones, nerves, secondary signals, or other metabolites may carry the response forward.
It means the route must be demonstrated.
Duration and repetition matter
Cells respond not only to concentration but also to time.
A brief post-meal pulse differs from continuous exposure. Repeated bean-containing meals may create recurring periods of substrate delivery and microbial metabolism. Habitual intake may also change the microbial community, transport capacity, enzyme expression, and baseline metabolic environment.
Some responses occur in seconds or minutes through receptors, channels, and phosphorylation. Others require hours because transcription and protein production must change. Tissue adaptation may require repeated exposures over days or longer.
This gives the Bean’s Journey a rhythm.
One meal creates an event.
A dietary pattern repeats the event and may alter the system receiving the next meal.
The Bean’s Journey: exposure becomes response
The bean has reached several cellular recipients.
Small-intestinal cells sensed glucose, amino acids, and the composition of the meal. Colonocytes transported and used microbial butyrate. Enteroendocrine cells translated local chemistry into hormonal signals. Immune cells encountered metabolites within intestinal tissue. Portal blood carried absorbed products to the liver.
The bean did not send one instruction.
It changed the chemical environment in which many cells made decisions.
Transporters determined entry. Receptors initiated signaling. Enzymes transformed substrates. Metabolism altered energy and redox state. Hormonal and neural pathways extended local sensing to distant organs.
The molecule supplied the possibility.
The cell determined the response.
What the evidence can establish at this stage
Receptor-binding experiments can show that a molecule activates a receptor. Transport studies can establish movement across a membrane. Cell culture and organoids can reveal signaling or transcriptional responses. Human tissue can confirm that the relevant machinery is present. Infusion studies can test physiological responses at defined sites and doses. Feeding trials can determine whether eating beans produces the exposure and response in people.
Each level answers a different question.
Expression of a receptor does not prove meaningful activation after a meal. Activation in a mouse does not guarantee the same response in a human. A response in a transformed cell line may not occur in normal tissue. Direct infusion of a metabolite bypasses microbial production and may create a different exposure from eating beans.
Cellular sensing establishes bioactivity only when the chemical form, concentration, location, and duration are relevant.
Even then, bioactivity is not yet a health effect.
The cell must translate sensing into changed biological work.
The Bean at This Stage
Products of the bean have been detected by cells.
Some entered through transporters. Some activated receptors. Some became metabolic substrates. Some altered intracellular enzymes. Intestinal cells released hormones, local immune cells responded, and the liver began integrating portal exposures.
The bean’s transformed products have changed the conditions inside or around cells and engaged systems capable of responding.
The next question is how those signals change cellular priorities—including which genes are transcribed and which proteins are produced.
Next — Gene Regulation: Changing Cellular Priorities
Cells cannot respond to every exposure by rewriting their DNA sequence.
They respond by changing how existing genetic information is used.
Signaling pathways activate transcription factors. Chromatin becomes more or less accessible. Histone modifications, DNA methylation, regulatory RNA, and metabolic cofactors influence gene activity.
The next chapter explains how products of the Bean’s Journey can contribute to those regulatory conditions—without claiming that a bean simply turns genes on or off.
Notes and selected references
- Cuff MA, Lambert DW, Shirazi-Beechey SP. Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1. Journal of Physiology. 2002;539(Pt 2):361–371. doi:10.1113/jphysiol.2001.014241.
- Larraufie P, Martin-Gallausiaux C, Lapaque N, Doré J, Gribble FM, Reimann F, Blottière HM. Short-chain fatty acids strongly stimulate PYY production in human enteroendocrine cells. Scientific Reports. 2018;8:74. doi:10.1038/s41598-017-18259-0.
- Rosseel R, Vandermeulen G, Dehau T, Verbeke K. Small intestinal compared with colonic short-chain fatty acid delivery drives distinct systemic concentrations and endocrine responses in humans: a randomized, crossover trial. American Journal of Clinical Nutrition. 2026. doi:10.1016/j.ajcnut.2026.101470.
- Parada-Venegas D, De la Fuente López M, Dubois-Camacho K, et al. Butyrate suppresses mucosal inflammation in inflammatory bowel disease primarily through HDAC3 inhibition in monocytes and macrophages. FEBS Journal. 2025;292(22):6134–6157. doi:10.1111/febs.70289.
- Boets E, Gomand SV, Deroover L, et al. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study. Journal of Physiology. 2017;595(2):541–555. doi:10.1113/JP272613.